Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Cancer

Cancer

Page 23 of 26

Andy Grove, Engineer: Rest in Peace
Tech

Andy Grove, Engineer: Rest in Peace

By Clifton Leaf and David Agus
March 22, 2016
Cancer research laboratory
Tech

Could a Massive Data Dump Help Solve Breast Cancer?

By Hilary Brueck
March 8, 2016
Doctors Seek Higher Fees From Health Insurers
Commentary

Why a Cure For Cancer Is Possible

By Robert Mulroy
March 1, 2016
Cancer research laboratory
Health

Pharma’s Big New Cancer Drug May Be an Old Red Dye

By Reuters
February 26, 2016
LS010183
Health

Scientists Say a Talc and Cancer Link Is Hard to Pin Down

By Reuters
February 25, 2016
claire mccaskill
Leadership

Sen. Claire McCaskill Says She Has Breast Cancer

By Daniel White and TIME
February 22, 2016
Preparations For The World Economic Forum (WEF) 2016
Tech

Everything You Need to Know About the White House’s Cancer Moonshot

By Hilary Brueck
February 1, 2016
The 363-foot-high Saturn V rocket for the Apollo 10 mission towers over the crawlerway during its rollout from the Vehicle Assembly Building to Launch Pad 39B, four miles away. Apollo 10 marked the first use of Pad B. Astronauts Thomas P. Stafford and Eugene A. Cernan descended in a lunar module spacecraft to 50,000 feet above the moon's surface while John W. Young orbited above in the command module. Image credit: NASA March 11, 1969
Leadership

A ‘Cancer Moonshot,’ You Say? Start Paving

By Clifton Leaf
January 29, 2016
This Microscope Can Detect Cancer Without a Biopsy

This Microscope Can Detect Cancer Without a Biopsy

By Hilary Brueck
January 28, 2016
Preparations For The World Economic Forum (WEF) 2016
Leadership

Biden Pledges Faster U.S. Approval for Cancer Drug Cocktails

By Reuters
January 19, 2016
President Obama Puts Joe Biden in Charge of Curing Cancer
Leadership

President Obama Puts Joe Biden in Charge of Curing Cancer

By Charlotte Alter and TIME
January 13, 2016
Bill Gates and Jeff Bezos Are Backing This New Cancer Testing Company
Health

Bill Gates and Jeff Bezos Are Backing This New Cancer Testing Company

By Reuters
January 11, 2016
The 22nd annual Susan G. Komen Race for the Cure in Denver, CO.
Health

Cancer Deaths Are Plummeting to Lowest in Decades

By Laura Lorenzetti
January 8, 2016
Smokers
Health

Up to 90% of Cancer Cases Caused by Lifestyle or Environment, Study Says

By Dan Mitchell
December 17, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

AstraZeneca Wants a Stake in This Biotech Firm for a Cancer Cure

By Reuters
December 17, 2015

Most Popular

  • Success
    In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
    By Emma Burleigh
  • Politics
    Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
    By Tristan Bove
  • Cybersecurity
    Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
    By Eva Roytburg
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.